RNA Targeting Small Molecule Drug Discovery Global Market Report 2024 Global Market Analysis, Trends, Growth, Research And Forecast 2033

The new report published by The Business Research Company, titled RNA Targeting Small Molecule Drug Discovery Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the rna targeting small molecule drug discovery market size has grown exponentially in recent years. It will grow from $1.45 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 22.3%. The rna targeting small molecule drug discovery market size is expected to see exponential growth in the next few years. It will grow to $3.97 billion in 2028 at a compound annual growth rate (CAGR) of 22.2%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12480&type=smp

Rising Disease Burden Is A Catalyst For Growth In Rna-Targeted Small-Molecule Drug Discovery Market
The increasing prevalence of cancer, genetic disorders, and viral infections is expected to propel the growth of the RNA-targeted small-molecule drug discovery market going forward. Cancer is a group of diseases characterized by the uncontrollable growth of cells in the body. Viral infections refer to infections caused by viruses, tiny infectious agents that can only replicate inside the cells of living organisms. RNA targeting-based drug discovery is used to treat cancer, genetic disorders, and viral infections, as these diseases are linked with genes and malfunctioning genetic material, which can be treated using drugs developed using RNA targeting-based methods. For instance, in February 2021, according to the American Cancer Society, a US-based voluntary Health Organization, new cancer cases and cancer deaths number is expected to increase by 47% by 2040, reaching about 28.4 million cases. Furthermore, in 2021, according to the World Health Organization, a Switzerland-based specialized health agency of the United Nations, approximately 38.4 million people were living with HIV, and 650,000 people died due to HIV. Therefore, the increasing prevalence of cancer, genetic disorders, and viral infections drives the growth of the RNA-targeted small-molecule drug discovery market.

Revolutionizing Small-Molecule Drug Discovery Through The Impact Of AI Integration In Pharmaceutical Research
Artificial intelligence (AI) integration in drug discovery is a key trend gaining popularity in the small-molecule drug discovery market. Major companies in the small molecule drug discovery market are leveraging AI technology to accelerate drug discovery procedures to sustain their position in the market. For instance, in May 2023, Google Cloud, the cloud computing suite of Google, a US-based technology company, launched Target and Lead Identification Suite and Multiomics Suite to facilitate the drug discovery process. The Multiomics Suite expedites the identification and analysis of genetic data, assisting businesses in designing precision medicines. The Target and Lead Identification Suite aids researchers in better understanding the role of amino acids and predicting the structure of proteins.

The rna targeting small molecule drug discovery market covered in this report is segmented -

1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)
2) By Technology: CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
4) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods
5) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other Applications

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12480&type=discount

Major companies operating in the rna targeting small molecule drug discovery market report are F. Hoffmann-La Roche Ltd , Merck & Co. Inc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk Inc., Moderna Inc., Astellas Pharma Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, Arbutus Biopharma Corporation, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics

Contents of the report:
1. Executive Summary
2. RNA Targeting Small Molecule Drug Discovery Market Report Structure
3. RNA Targeting Small Molecule Drug Discovery Market Trends And Strategies
4. RNA Targeting Small Molecule Drug Discovery Market - Macro Economic Scenario
5. RNA Targeting Small Molecule Drug Discovery Market Size And Growth
…..
27. RNA Targeting Small Molecule Drug Discovery Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecule-drug-discovery-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.